Literature DB >> 365711

Regulation of B cell unresponsiveness by suppressor cells.

D E Parks, W O Weigle.   

Abstract

Mesh:

Substances:

Year:  1979        PMID: 365711     DOI: 10.1111/j.1600-065x.1979.tb00423.x

Source DB:  PubMed          Journal:  Immunol Rev        ISSN: 0105-2896            Impact factor:   12.988


× No keyword cloud information.
  8 in total

1.  Isolation of a bovine serum albumin-specific T-suppressor cell clone and evaluation of its in vitro functions.

Authors:  J Degwert; R Bettmann; J Heuer; E Kölsch
Journal:  Immunology       Date:  1987-03       Impact factor: 7.397

2.  Tolerance: facts and views--1983.

Authors:  D E Parks
Journal:  Surv Immunol Res       Date:  1984

3.  Tolerance and immunity in mice infected with herpes simplex virus: studies on the mechanism of tolerance to delayed-type hypersensitivity.

Authors:  A A Nash; J Phelan; P G Gell; P Wildy
Journal:  Immunology       Date:  1981-06       Impact factor: 7.397

Review 4.  Current perspectives on the cellular mechanisms of immunologic tolerance.

Authors:  D E Parks; W O Weigle
Journal:  Clin Exp Immunol       Date:  1980-02       Impact factor: 4.330

5.  B-lymphocyte activation with an extract of Nocardia brasiliensis.

Authors:  L Ortiz-Oritz; D E Parks; J S Lopez; W O Weigle
Journal:  Infect Immun       Date:  1979-08       Impact factor: 3.441

6.  A human soluble suppressor factor affecting lymphocyte responses in vitro.

Authors:  L Shou; S A Schwartz; R A Good; R Peng; C L Chen
Journal:  Proc Natl Acad Sci U S A       Date:  1980-10       Impact factor: 11.205

7.  Induction and mode of action of suppressor cells generated against human gamma globulin. II. Effects of colchicine.

Authors:  D E Parks; D A Shaller; W O Weigle
Journal:  J Exp Med       Date:  1979-05-01       Impact factor: 14.307

8.  Allosuppressor and allohelper T cells in acute and chronic graft-vs-host disease. V. F1 mice with secondary chronic GVHD contain F1-reactive allohelper but no allosuppressor T cells.

Authors:  S T Pals; H Gleichmann; E Gleichmann
Journal:  J Exp Med       Date:  1984-02-01       Impact factor: 14.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.